Shuang Dai

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Radical Prostatectomy

Mesenchymal Stem Cells

Acute Lymphoblastic Leukemia

Top Venues

Cancer medicine

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Shuang Dai, Yong Zhang, Xiang Tan, Feng Luo, Xi Yan
Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective study. Cancer medicine 13 (11) (2024)
Shuang Dai, Yong Zhang, Xiang Tan, Feng Luo, Xi Yan
Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective study. Cancer medicine 13 (11) (2024)
Shuang Dai, Yong Zhang, Xiang Tan, Feng Luo, Xi Yan
Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective study. Cancer medicine 13 (11) (2024)
Shuang Dai, Yan-Yang Liu, Tao Liu, Yu Zhang, De-Yun Luo
Case report of penile cancer recurrence treated with cetuximab combined with anlotinib. Clinical case reports 10 (2) (2022)
Hongna Sun, Junnan Xu, Shuang Dai, Yiwen Ma, Tao Sun
Breast cancer brain metastasis: Current evidence and future directions. Cancer medicine (2022)